Edition:
United Kingdom

Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

82.02EUR
20 Apr 2018
Change (% chg)

€0.02 (+0.02%)
Prev Close
€82.00
Open
€82.00
Day's High
€82.04
Day's Low
€81.34
Volume
564,355
Avg. Vol
583,527
52-wk High
€115.20
52-wk Low
€74.54

Select another date:

Fri, Apr 20 2018

Photo

Germany's Merck seeks partners for cancer and immune system drugs

FRANKFURT Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.

FOCUS-Germany's Merck seeks partners for cancer and immune system drugs

* Merck needs development funding just as profit seen slipping

CORRECTED-P&G to acquire German Merck's consumer health business for about $4.21 bln

April 19 Procter & Gamble Co said on Thursday it has signed an agreement to acquire the consumer health business of German pharmaceuticals company Merck KGaA for about 3.4 billion euros ($4.21 billion).

BRIEF-Merck Says Signed Agreement To Sell Its Global Consumer Health Business To P&G For About 3.4 Bln Euros In Cash

* MERCK SAYS SIGNED AN AGREEMENT TO SELL ITS GLOBAL CONSUMER HEALTH BUSINESS TO PROCTER & GAMBLE FOR ABOUT 3.4 BILLION EUROS IN CASH Further company coverage:

BRIEF-P&G Acquires the Consumer Health Business Of Merck KGaA, Darmstadt, Germany

* ACQUIRES THE CONSUMER HEALTH BUSINESS OF MERCK KGAA, DARMSTADT, GERMANY

BRIEF-P&G Nears Deal To Acquire Merck KGaA's Consumer-Health Unit - WSJ

* P&G NEARS DEAL TO ACQUIRE MERCK KGAA’S CONSUMER-HEALTH UNIT - WSJ, CITING SOURCES Source text: https://on.wsj.com/2qHVGJh Further company coverage:

Mylan seeks deal for German Merck's consumer products unit: sources

FRANKFURT/NEW YORK Generic drug maker Mylan NV is in advanced discussions to acquire Merck KGaA's consumer health business after other bidders failed to meet the German company's price expectations, people familiar with the matter said.

Mylan seeks deal for German Merck's consumer products unit - sources

FRANKFURT/NEW YORK Generic drug maker Mylan NV is in advanced discussions to acquire Merck KGaA's consumer health business after other bidders failed to meet the German company's price expectations, people familiar with the matter said.

UPDATE 2-Mylan seeks deal for German Merck's consumer products unit -sources

FRANKFURT/NEW YORK, April 13 Generic drug maker Mylan NV is in advanced discussions to acquire Merck KGaA's consumer health business after other bidders failed to meet the German company's price expectations, people familiar with the matter said.

Mylan seeks deal for German Merck’s consumer products unit -sources

FRANKFURT/NEW YORK, April 13 Generic drug maker Mylan is in advanced discussions to acquire Merck KGaA’s consumer health unit after other bidders failed to meet the German company’s price expectations, people familiar with the matter said.

Select another date: